 |
 | |
 |  |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
Here is one stock that I think has a chance to be a fairy tale story, turn-around stock. The company is Chantal Pharmaceutical. It could also conceivably go bust, so be very careful. Invest only with money you can afford to lose. Chantal Pharmaceutical Corp. is one of my favorite micro-cap company special situations. They are a pharmaceutical company that primarily markets a line of skin care products based on the use of a new coumpound called "Ethocyn" which is supposed to help repair/increase the elastomers in your skin. If this is the case, then it might be a true wrinkle eliminator/smoother. Some participants in a "half face" contest are being featured in advertising with results quite remarkable to me where they used it on half of their face only. There have been studies by a Professor of Dermatology at the UCLA Medical Center showing a significant increase in the skin's elastin fiber production after 2 months in patients in the study. Chantal also engages in other research and development efforts on products for androgen mediated disorders such as acne, hirsutism, male pattern baldness, benign prostate hypertrophy and treatment of certain cancers. Cytocol and Metcyclor are the company's two other potentially significant patented compounds. The company has been through a series of disasters (which was also disastrous for the share price and many shareholders) and despite all that has happened, things are looking better to me at CHTL lately. In 1995, CHTL soared and made some folks very happy. But then, Chantal collapsed from over $28 per share in the end of 1995/early 1996, to its current level. It started with a negative article in Barrons which raised a number of questions and caused the stock to plunge and a lot of media attention to turn away at that time which hurt marketing and other efforts at the company. A shareholder lawsuit also ensued. They had delays with their accounting as they were getting an inventory system working with their marketing partner Stanson Marketing. One of the accounting firms resigned and another subsequently hired. CHTL was warned for the late filing by the SEC. There is a lot of information in the other CHTL thread on SI and elsewhere on the web on past events and the financials. But since that time, things are looking up to me. I still think there are major hurdles to be jumped for this company, but my feeling is that the tide has turned for CHTL. Ethocyn appears to me to work. The "half face" contest results are very convincing in my opinion as was the clinical study by the UCLA professor. The company has agreements with David Hasselhoff of the hit TV series "Baywatch" for promotion of Ethocyn skin care products. Hasselhoff can probably endorse any product he wants, so he must see some potential for the product which he is reported to use as he works in the hot sun on the Baywatch set. Sales are expanding internationally in Asia and Europe this year for the first time. Chantal has elected 5 new board members who will add a lot of industry experience to the company. I highly recommend reading their personal profiles. The company is intending to terminate its marketing agreement with Stanson Marketing which I feel will increase their profitability on their US sales. In addition to the recent election/re-election of all of the board members and with the appointment of Polly Bergen as COO, the company just got authorization to issue up to 50 million shares which greatly increases their ability to finance future growth. The Dream The dream here is that CHTL has indeed turned the corner on its recent past. If the company survives, then in the dream, it returns to its former high of over $28. That would make a Million dollar plus position out of a relatively tiny $30K investment now..... It's been there before, can it do it again??? | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |